AssuredPartners Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$529K Sell
6,135
-2,072
-25% -$198K 0.06% 243
2025
Q4
$788K Buy
8,207
+5,506
+204% +$535K 0.12% 164
2025
Q3
$257K Buy
+2,701
New +$248K 0.06% 224
2025
Q2
Sell
-11,555
Closed -$1.04M 300
2025
Q1
$1.04M Buy
11,555
+34
+0.3% +$3.04K 0.2% 123
2024
Q4
$920K Buy
+11,521
New +$997K 0.18% 129

Other funds holding MDT

AssuredPartners Investment Advisors's MDT Position: Q1 2026 in Review

AssuredPartners Investment Advisors reduced its Medtronic (MDT) stake by 25% in Q1 2026, selling an estimated $198K and leaving 6,135 shares worth $529K. The position accounts for 0.06% of the portfolio, ranked #243.

AssuredPartners Investment Advisors first reported a position in MDT in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.04M in Q1 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • AssuredPartners Investment Advisors held 6,135 shares of Medtronic worth $529K as of Q1 2026.
  • AssuredPartners Investment Advisors sold 2,072 Medtronic shares in Q1 2026, an estimated $198K.
  • Medtronic made up 0.06% of AssuredPartners Investment Advisors's portfolio in Q1 2026, its #243 holding.
  • AssuredPartners Investment Advisors first reported a position in Medtronic in Q4 2024 and has held it in 5 quarters since.
  • AssuredPartners Investment Advisors's Medtronic position peaked at $1.04M in Q1 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on AssuredPartners Investment Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.